首页> 外文期刊>ACS medicinal chemistry letters >Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration
【24h】

Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration

机译:通过酶模板片段修饰发现二价激酶抑制剂

获取原文
获取原文并翻译 | 示例
       

摘要

We have employed novel fragment-based screening methodology to discover bivalent kinase inhibitors with improved selectivity. Starting from a low molecular weight promiscuous kinase inhibitor, we appended a thiol for subsequent reaction with a library of acrylamide electrophiles. Enzyme-templated screening was performed to identify acrylamides that assemble into bivalent inhibitors of c-Src kinase. Upon identification of acrylamide fragments that improve the binding affinity of our lead thiol, we characterized the resulting bivalent inhibitors and identified a series of kinase inhibitors with improved potency and selectivity compared to the thiol-containing precursor. Provided that protein can be prepared free of endogenous reactive cysteines, our methodology is general and could be applied to nearly any enzyme of interest.
机译:我们采用了新颖的基于片段的筛选方法来发现具有提高的选择性的二价激酶抑制剂。从低分子量混杂激酶抑制剂开始,我们附加了硫醇,用于随后与丙烯酰胺亲电试剂库的反应。进行了以酶为模板的筛选,以鉴定组装成c-Src激酶二价抑制剂的丙烯酰胺。在鉴定出可改善我们的硫醇铅结合亲和力的丙烯酰胺片段后,我们对所得的二价抑制剂进行了表征,并鉴定了一系列与含硫醇的前体相比具有增强的效能和选择性的激酶抑制剂。如果可以制备不含内源性反应性半胱氨酸的蛋白质,则我们的方法是通用的,可以应用于几乎任何感兴趣的酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号